1.Siwo, G, Williams, S, Moore, J. The future of genomic medicine education in Africa. Genome Medicine 2015; 7: 47.
2.Mitropoulos, K, et al. Success stories in genomic medicine from resource-limited countries. Human Genomics 2015; 9: 11.
3.Nordling, L. How the genomics revolution could finally help Africa. Nature News 2017; 544: 20–22.
4.Gross, R, et al. Slow efavirenz metabolism genotype is common in Botswana. Journal of Acquired Immune Deficiency Syndromes (1999) 2008; 49: 336–337.
5.International Human Genome Sequencing Consortium. Initial sequencing and analysis of the human genome. Nature 2001; 409: 860–921.
6.Schuster, SC, et al. Complete Khoisan and Bantu genomes from Southern Africa. Nature 2010; 463: 943–947.
7.Ramsay, M, et al. Africa: the next frontier for human disease gene discovery? Human Molecular Genetics 2011; 20: R214–R220.
8.Wonkam, A, Njamnshi, AK, Angwafo, FF III. Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genetics in Medicine 2006; 8: 331–338.
9.Wonkam, A, Mayosi, BM. Genomic medicine in Africa: promise, problems and prospects. Genome Medicine 2014; 6: 11.
10.Singer, PA, Daar, AS. Harnessing genomics and biotechnology to improve global health equity. Science 2001; 294: 87.
11.Gurdasani, D, et al. The African genome variation project shapes medical genetics in Africa. Nature 2015; 517: 327–332.
12.H3Africa Consortium. Enabling the genomic revolution in Africa. Science 2014; 344: 1346–1348.
13.Malaria Genomic Epidemiology Network. A global network for investigating the genomic epidemiology of malaria. Nature 2008; 456: 732–737.
14.Kromberg, JGR, Sizer, EB, Christianson, AL. Genetic services and testing in South Africa. Journal of Community Genetics 2013; 4: 413–423.
15.Charmaz, K. Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis 2006 224 ed. London, UK: SAGE Publications Ltd.
16.Devers, KJ, Frankel, RM. Study design in qualitative research—2: sampling and data collection strategies. Education for Health 2000; 13: 263.
17.Munung, NS, Mayosi, BM, de Vries, J. Equity in international health research collaborations in Africa: perceptions and expectations of African researchers. PLoS ONE 2017; 12: e0186237.
18.Bello-Manga, H, DeBaun, MR, Kassim, AA. Epidemiology and treatment of relative anemia in children with sickle cell disease in sub-Saharan Africa. Expert Review of Hematology 2016; 9: 1031–1042.
19.Beighton, P, et al. UCT's contribution to medical genetics in Africa – from the past into the future. South African Medical Journal 2012; 102: 446–448.
20.Urban, MF. Genomics in medicine: from promise to practice. SAMJ 2015; 105: 545–547.
21.Netto, GJ, Saad, RD, Dysert, PA. Diagnostic molecular pathology: current techniques and clinical applications, part I. Proceedings (Baylor University Medical Center) 2003; 16: 379–383.
22.Gahl, WA, et al. The National Institutes of Health Undiagnosed Diseases Program: insights into rare diseases. Genetics in Medicine 2012; 14: 51–59.
23.Spear, BB, Heath-Chiozzi, M, Huff, J. Clinical application of pharmacogenetics. Trends in Molecular Medicine 2001; 7: 201–204.
25.Masimirembwa, C, Hasler, JA. Pharmacogenetics in Africa, an opportunity for appropriate drug dosage regimens: on the road to personalized healthcare. CPT: Pharmacometrics & Systems Pharmacology 2013; 2: e45.
26.Nyakutira, C, et al. High prevalence of the CYP2B6 516G->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe. European Journal of Clinical Pharmacology 2008; 64: 357–365.
27.Struelens, MJ, Brisse, S. From molecular to genomic epidemiology: transforming surveillance and control of infectious diseases. Euro Surveillance 2013; 18: 20386.
28.Lienau, EK, et al. Identification of a salmonellosis outbreak by means of molecular sequencing. New England Journal of Medicine 2011; 364: 981–982.
29.Gire, SK, et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 2014; 345: 1369–1372.
30.Boulyjenkov, V, Schapper, C. The Ethical, Legal and Social Implications of Pharmacogenomics in Developing Countries: Report of an International Group of Experts. WHO: Geneva, Switzerland. 2007, p. 72.
31.Phillips, KA, et al. The economic value of personalized medicine tests: what we know and what we need to know. Genetics in Medicine 2014; 16: 251–257.
32.Alyass, A, Turcotte, M, Meyre, D. From big data analysis to personalized medicine for all: challenges and opportunities. BMC Medical Genomics 2015; 8: 33.
33.Shabaruddin, FH, Fleeman, ND, Payne, K. Economic evaluations of personalized medicine: existing challenges and current developments. Pharmacogenomics and Personalized Medicine 2015; 8: 115–126.
34.Seguin, B, et al. Genomic medicine and developing countries: creating a room of their own. Nature Reviews Genetics 2008; 9: 487–493.
35.Benatar, SR. Commentary: justice and medical research: a global perspective. Bioethics 2001; 15: 333–340.
36.Pratt, B, Loff, B. A framework to link international clinical research to the promotion of justice in global health. Bioethics 2014; 28: 387–396.
37.Tiffin, N. Unique considerations for advancing genomic medicine in African populations. Personalized Medicine 2014; 11: 187–196.
38.Burke, W, et al. The path from genome-based research to population health: development of an international public health genomics network. Genetics in Medicine 2006; 8: 451–458.
39.Daar, AS, Sahni, P, Singer, PA. Genomics, biotechnology and global health: the work of the University of Toronto Joint Centre for Bioethics. Acta Bioethica 2004; X: 213–225.
40.Burgner, D, Jamieson, SE, Blackwell, JM. Genetic susceptibility to infectious diseases: big is beautiful, but will bigger be even better? The Lancet Infectious Diseases 2006; 6: 653–663.
41.Hill, AV. Genetics and genomics of infectious disease susceptibility. British Medical Bulletin 1999; 55: 401–413.
42.Newport, MJ, Finan, C. Genome-wide association studies and susceptibility to infectious diseases. Briefings in Functional Genomics 2011; 10: 98–107.
43.Harris, E, Belli, A, Agabian, N. Appropriate transfer of molecular technology to Latin America for public health and biomedical sciences. Biochemical Education 1996; 24: 3–12.
44.Ruger, JP. Global health justice. Public Health Ethics 2009; 2: 261–275.
45.WHO. Global World Estimates: Burden of Disease by Cause, Age, Sex, by Country and by Region, 2000–2015. World Health Organisation: Geneva, 2016.